Older women who are being treated with trastuzumab (Herceptin),
alone or with a class of chemotherapy drugs called
anthracyclines, may be at increased risk for heart failure and
heart muscle damage.
To continue reading this article, you must login
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.